Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h


+3226269640
Google maps


Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :
TAGS

22/05/2015
Bacterial communities of the female genital tract have an impact on inflammation, HIV risk

Most common bacteri al community in healthy South African women may increase presence of T cells targeted by HIV A team led by researchers from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard has found that the most common bacterial community in the genital tract among healthy South Africa women not only is significantly different from that...

Read more...





22/05/2015
Lower daily tenofovir dose of 150 mg safe and effective in people with moderate renal impairment

A reduced tenofovir ( Viread ) dose of 150mg daily appears to be a safe and effective treatment for people with HIV who have moderate renal impairment, investigators from Thailand report in the online edition of Clinical Infectious Diseases . The 150mg daily dose provided comparable drug exposure to the currently recommended dose of 300mg every 48 hours. Moreover, treatment with...

Read more...

Source Source: Aidsmap





22/05/2015
'Imperfect drug penetration' speeds pathogens' resistance, study finds

Doctors should consider drug combinations that reach similar parts of the body, researchers suggest SAN FRANCISCO, May 18, 2015 -- Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings of the National...

Read more...





21/05/2015
Patent challenges in five countries dispute validity of Gilead's claims to hep C drug patents that block treatment for up to 59 million people

I-MAK leading patent challenges as core treatment advocacy strategy to remove barriers to medicine worldwide Escalating global movement to fight Gilead's patent abuse and ensure people with hepatitis C get care grows to three continents NEW YORK , May 20, 2015 /RPNewswire/ -- Pharmaceutical corporation Gilead is seeking illegitimate patents for hepatitis C medicine...

Read more...

Source Source: PRNewswire





21/05/2015
New MdM report - healthcare far from universally accessible throughout Europe

Europe is the cradle of human rights – the range of international texts and State commitments that ensure people’s basic and universal rights is impressive. Yet this report shows how, in practice, these promises too often remain just words rather than effective progress. The complete report, that presents the results of all the analyses, is available here . The...

Read more...